APEXCELLA
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99091453
- Mark type
- Design + words
- Filed
- 19 Mar 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Joseph Bruce
Goods and services
- Class 005 — Pharmaceuticals: Immunostimulants; Cells for medical use; Biological tissue cultures for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical agents for treating aging, oncology and autoimmune disease; Antivirals; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical products for the prevention and treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use
- Class 042 — Scientific and technological services: Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting of feasibility studies in the field of new technologies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Custom design of prototypes; Quality control of goods and services; Product quality testing services
Owner
- Apexcella Biomedical Inc., Taipei City, TW
- Apexcella Biomedical Inc., Taipei City, TW
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2025 — ASSIGNED TO EXAMINER
- 05 Aug 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 05 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Mar 2025 — NEW APPLICATION ENTERED